OncoAID
Welcome to OncoAID
OncoAID is an open-access, free-to-use database of targeted anti-cancer drugs and regimens. Explore the full resource in the link below
What you’ll find inside
Comprehensive coverage – FDA-approved monotherapy and combination therapies, plus current approval status from other regulatory agencies (e.g., EMA, WHO). Where available, each entry includes progression-free survival (PFS) and overall survival (OS) outcomes.
Molecular detail – drug targets, gene/protein annotations and actionable biomarkers, with direct links for further information.
AI-enhanced insights – GPT- and Perplexity-generated clinical summaries that synthesize key trial data and expert commentary.
Research-friendly design – a clean interface built to help data scientists, clinicians and engineers drive future precision-oncology practice and research.
If OncoAID supports your work, please cite:
Landau O, Magidi S, Bresson C, Wunder F, Kurzrock R, El-Deiry WS, Thangathurai K, Rubin E. OncoAID: An Open Access Targeted Anti-Cancer Drugs Database.